Fiduciary Trust Co. Sells 29 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Fiduciary Trust Co. decreased its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,480 shares of the biopharmaceutical company’s stock after selling 29 shares during the quarter. Fiduciary Trust Co.’s […]

Related Keywords

Alaska ,United States ,Huday Zoghbi ,Marion Mccourt ,Regeneron Pharmaceuticals Inc ,News Ratings For Regeneron Pharmaceuticals Daily ,Exchange Commission ,Canaccord Genuity Group ,Crossmark Global Holdings Inc ,Century Group ,Regeneron Pharmaceuticals Stock Performance ,Quarter For Regeneron Pharmaceuticals ,Regeneron Pharmaceuticals ,Courier Capital ,Wealthspire Advisors ,Regeneron Pharmaceuticals Profile ,Alaska Permanent Fund Corp ,Nasdaq ,Fiduciary Trust ,Free Report ,Permanent Fund Corp ,Global Holdings ,Genuity Group ,Get Free Report ,Director Huda ,Visit Holdingschannel ,Regeneron Pharmaceuticals Daily ,Nasdaq Regn ,Regn ,Medical ,75886f10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,